(IN BRIEF) Evonik, the global specialty chemicals company, has won the Best New Bioprocessing Supplier in Upstream Processing award for its innovative Cell Culture Solutions portfolio at the Asia-Pacific Bioprocessing Excellence Awards (ABEA). The awards celebrate exceptional organizations and technologies … Read the full press release
(IN BRIEF) The Food and Drugs Authority of Ghana has granted full national licensure for the R21/Matrix-M malaria vaccine developed by the University of Oxford and manufactured by the Serum Institute of India using Novavax’s adjuvant technology. This marks the … Read the full press release
Posted in Business, Education, Healthcare, Management, News, Pharma & Biotech, Science, United Kingdom
Tagged Adar Poonawalla, CHILDREN, Dr Kofi Nsiah-Poku, FDA Ghana, GHANA, John C. Jacobs, malaria vaccine, Novavax, Oxford, Prof. Adrian Hill, R21/Matrix-M malaria vaccine, Serum Institute of India, University of Oxford
(NOTIZIA IN BREVE) La Banca europea per gli investimenti (BEI) ha investito 15 milioni di euro in Neuromod Devices Ltd per supportare la commercializzazione del suo dispositivo per il trattamento dell’acufene, Lenire. Il dispositivo ha ottenuto l’approvazione De Novo dalla … Read the full press release
Posted in Banks, European Union, Financial, Healthcare, Investment, Ireland, Pharma & Biotech
Tagged Alessio Beverina, bimodal neuromodulation device, De Novo, dispositivo di neuromodulazione bimodale, dispositivo medico, dispositivo per il trattamento dell'acufene, Dr. Manus Rogan, Dr. Ross O’Neill, European Investment Bank, FDA, Fountain Healthcare Partners, Lenire, medical device, Neuromod Devices Ltd, neuromodulation, neuromodulazione, Panakès Partners, Scientific Reports, TENT-A1, TENT-A2, Thomas Östros, tinnitus, tinnitus treatment device
(IN BRIEF) The European Investment Bank (EIB) has invested €15 million in Neuromod Devices Ltd to support the commercialization of its tinnitus treatment device, Lenire. The device has been granted De Novo approval from the US FDA and has shown … Read the full press release
Posted in Banks, European Union, Financial, Healthcare, Investment, Ireland, Pharma & Biotech
Tagged Alessio Beverina, bimodal neuromodulation device, De Novo, Dr. Manus Rogan, Dr. Ross O’Neill, European Investment Bank, FDA, Fountain Healthcare Partners, Lenire, medical device, Neuromod Devices Ltd, neuromodulation, Panakès Partners, Scientific Reports, TENT-A1, TENT-A2, Thomas Östros, tinnitus, tinnitus treatment device
(IN BRIEF) The Conference Forum has announced that the 7th annual European Patients as Partners® in Clinical Research conference will take place in London on June 12-13, 2023. The event will focus on achieving greater representation in clinical research, building … Read the full press release
Posted in Government, Healthcare, News, Non Profit, Pharma & Biotech, United Kingdom
Tagged 7th annual European Patients as Partners®, biotechnology, Boehringer Ingelheim, Center for BME Health, clinical development, clinical research, Clinical Research conference, clinical trials, Community Engagement, CSL Behring, Deirdre BeVard, Diversity in Clinical Research, drug development, government, Health Equity, Healthcare, Hospital, Lundbeck, Medicine Development, Medicine Lifestyle, Medicines Development, Novartis, Patient Advocacy, Patient Centricity, Patient Communities, patient engagement, Patient Perspective, Patient Recruitment, Patient Retention, Patient Voice, Patients as Partners, Pharmaceutical, research and development, Sanofi, The Conference Forum, Thistle Hotel Marble Arch, Valerie Bowling
(ACTUALITÉ EN BREF) Novo Nordisk a annoncé une collaboration avec Aspect Biosystems pour développer des thérapies tissulaires bio-imprimées pour le traitement du diabète et de l’obésité. La collaboration tirera parti de la technologie de bioimpression d’Aspect et de l’expertise de … Read the full press release
(IN BRIEF) Novo Nordisk has announced a collaboration with Aspect Biosystems to develop bioprinted tissue therapeutics for diabetes and obesity treatment. The collaboration will leverage Aspect’s bioprinting technology and Novo Nordisk’s expertise in stem cell differentiation and cell therapy development … Read the full press release
(IN BRIEF) Sanofi has simplified its contractual arrangements with AstraZeneca and Sobi for the development and commercialization of Beyfortus (nirsevimab) in the United States. Under the new arrangements, Sanofi will have full commercial control of nirsevimab in the U.S. Sanofi … Read the full press release
Posted in Business, France, Healthcare, Industrial, Management, News, Pharma & Biotech
Tagged AstraZeneca, Beyfortus, commercialization, contractual agreements, nirsevimab, partnership, Sanofi, Sobi, USA
(IN BRIEF) Researchers have used neutrons from the Research Neutron Source Heinz Maier-Leibnitz to explore the structure of biomolecules, specifically a promising vaccine against multidrug resistant bacteria. The vaccine consists of biomolecules with sizes in the order of 100 nanometers, … Read the full press release
Posted in Education, Germany, Healthcare, Management, News, Pharma & Biotech, Science
Tagged analysis, bacteria, biomolecules, Dr. Marco Maccarini, neutron, vaccine development
(IN BRIEF) A team led by Dr. Christoph F. Kurat from LMU’s Biomedical Center has discovered that a regular nucleosome structure is crucial for DNA replication to occur at certain points in the genome. Contrary to the textbook view that … Read the full press release
Posted in Education, Germany, Healthcare, Management, News, Pharma & Biotech, Science
Tagged cell nucleus, chromatin, DNA, Dr. Christoph F. Kurat, Erika Chacin, histones, LMU, nucleosomes, protein complex ORC, replication
(ACTUALITÉ EN BREF) Nordic Investment Bank (NIB) et Elekta AB, un fabricant suédois d’équipements médicaux, ont conclu un accord de prêt de 50 millions d’euros sur 7 ans pour financer des investissements de R&D dans des solutions et des traitements … Read the full press release
Posted in Banks, Financial, Finland, Healthcare, Investment, Pharma & Biotech, Sweden, Technology
Tagged André Küüsvek, apprentissage automatique, brachythérapie, Elekta AB, fabricant de matériel médical, financement, intelligence artificielle, Maurits Wolleswinkel, NIB, Pret, radiochirurgie, radiothérapie, soins avancés contre le cancer, solutions oncologiques, traitement oncologique
(IN BRIEF) Nordic Investment Bank (NIB) and Elekta AB, a Swedish medical equipment manufacturer, have agreed to a 7-year loan deal worth €50 million to finance R&D investments in oncology solutions and treatment. The loan will support Elekta’s research and … Read the full press release
Posted in Banks, Financial, Finland, Healthcare, Investment, Pharma & Biotech, Sweden, Technology
Tagged advance cancer care, André Küüsvek, artificial intelligence, brachytherapy, Elekta AB, financing, loan, Machine Learning, Maurits Wolleswinkel, medical equipment manufacturer, NIB, oncology solutions, oncology treatment, radiation therapy, radiosurgery
(IN BRIEF) Bayer has announced the recipients of its 2023 Grants4Ag program, which will provide funding and mentorship to researchers working on sustainability and biotechnology in agriculture. The program will award grants ranging from €5,000 to €15,000 and connect researchers … Read the full press release
Posted in Agriculture, Awards, Business, Germany, Management, News, Pharma & Biotech, Science, Technology
Tagged agriculture, Awards, Bayer, biotechnology, Dr. Phil Taylor, grants, Grants4Ag program, innovative, mentorship, Prof. Ji Zhou, researchers, sustainability
(NOTICIA EN BREVE) Kuehne+Nagel, una empresa de logística global, ha abierto un nuevo centro de cumplimiento de logística de contratos en el Aeropuerto Internacional de Dallas/Fort Worth. El centro logístico de 400 000 pies cuadrados está ubicado a tres millas de … Read the full press release
Posted in Business, Healthcare, Industrial, Infrastructure & Utilities, Pharma & Biotech, Switzerland, Transportation & Logistics
Tagged Aeropuerto Internacional de Dallas/Fort Worth, atención médica, cámaras frigoríficas, centro logístico, cumplimiento de grado farmacéutico, Eduardo Razuck, farmacéutica, Kuehne+Nagel, logistica, logística de contratos, Marcello Ferrari
(IN BRIEF) Kuehne+Nagel, a global logistics company, has opened a new contract logistics fulfillment center at the Dallas/Fort Worth International Airport. The 400,000 sq. ft fulfillment center is located three miles from the terminals and will offer storage solutions to … Read the full press release
Posted in Business, Healthcare, Industrial, Infrastructure & Utilities, Pharma & Biotech, Switzerland, Transportation & Logistics
Tagged cold chambers, contract logistics, Dallas/Fort Worth International Airport, Eduardo Razuck, fulfillment center, Healthcare, Kuehne+Nagel, logistics, Marcello Ferrari, pharma-grade compliant, Pharmaceutical
(IN BRIEF) YURiA-PHARM, a leading Ukrainian pharma company, has acquired Reka-Med, a pharmaceutical company in Uzbekistan, with the help of €10 million of finance repurposed from an existing loan made by the European Bank for Reconstruction and Development (EBRD). The … Read the full press release
Posted in Banks, Business, Economy, Financial, Industrial, Investment, Management, News, Pharma & Biotech, United Kingdom
Tagged ACQUIRES, EBRD, financing, Matteo Patrone, Reka-Med, UK, UKRAINE, Uzbekistan, YURiA-PHARM
AN INTERNATIONAL COLLABORATION OF HIGH-PROFILE EXPERTS DEFINED READY-TO-UPSCALE GREEN CHEMICALS AND TECHNOLOGIES FOR THE WOOD-TO-TEXTILE VALUE CHAIN (IN BRIEF)The GRETE project, an international collaboration of experts aimed at reducing the environmental footprint of the textile industry, presented their achievements to … Read the full press release
Posted in Apparel, Fashion & Beauty, Automotive, Chemicals, Commodities, Economy, Education, Electronics & Machinery, Energy, Gas & Oil, Environment, Government, Industrial, Infrastructure & Utilities, Pharma & Biotech, Science, Technology
Tagged 4th Cellulose Fibres Conference, bio based industry, bio based materials, cellulose dissolution, cellulose fibre, green chemicals, green industry, GRETE, ionic liquids, kraft pulp, Materially S.r.l., Metsä Group, novel liquid salts, process innovation, regenerated cellulose, solvent systems, sustainable textiles, textile fibres, textile industry, wood pulp modification, wood to textile
(IN BRIEF) Roche has announced a collaboration with Eli Lilly to support the development of its Elecsys Amyloid Plasma Panel (EAPP) which is an innovative blood test that aims to facilitate the earlier diagnosis of Alzheimer’s disease. The EAPP test … Read the full press release
(IN BRIEF) Bayer has launched a new water strategy at the UN 2023 Water Conference in New York, which aims to make water an integral part of its business decisions, investments, and supplier selection. The strategy reflects the company’s role … Read the full press release
Posted in Agriculture, Chemicals, Environment, Germany, Healthcare, Management, News, Pharma & Biotech, Technology
Tagged agriculture, Bayer, Corporate Water Stewardship, Cristina Alonso Alija, health, Werner Baumann
(IN BRIEF) BioNTech and OncoC4 have entered into an exclusive license and collaboration agreement to develop and commercialize OncoC4’s anti-CTLA-4 monoclonal antibody candidate, ONC-392. The candidate aims to delete immunosuppressive T cells in the tumor microenvironment but spare T cells … Read the full press release
Posted in Germany, Management, News, Pharma & Biotech, Science, Technology
Tagged anti-CTLA-4 monoclonal antibody, BioNTech, Germany, ONC-392, OncoC4, Prof. Ugur Sahin, T cells, Yang Liu
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?